Lara L. Chappell

1.2k total citations
17 papers, 970 citations indexed

About

Lara L. Chappell is a scholar working on Radiology, Nuclear Medicine and Imaging, Materials Chemistry and Oncology. According to data from OpenAlex, Lara L. Chappell has authored 17 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Materials Chemistry and 4 papers in Oncology. Recurrent topics in Lara L. Chappell's work include Radiopharmaceutical Chemistry and Applications (11 papers), Lanthanide and Transition Metal Complexes (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Lara L. Chappell is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Lanthanide and Transition Metal Complexes (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Lara L. Chappell collaborates with scholars based in United States and Slovakia. Lara L. Chappell's co-authors include Martin W. Brechbiel, Ekaterina Dadachova, Diane E. Milenic, Kayhan Garmestani, Janet R. Morrow, William DeW. Horrocks, Chuanchu Wu, Dangshe Ma, Jeffrey Schlom and Kim A. Deal and has published in prestigious journals such as Inorganic Chemistry, Bioconjugate Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Lara L. Chappell

17 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lara L. Chappell United States 16 625 248 189 173 162 17 970
Kavitha Sunassee United Kingdom 18 574 0.9× 232 0.9× 215 1.1× 129 0.7× 205 1.3× 37 1.2k
C. Greg Pippin United States 14 573 0.9× 216 0.9× 149 0.8× 160 0.9× 87 0.5× 22 841
Eric T. Clarke United States 16 334 0.5× 241 1.0× 78 0.4× 290 1.7× 76 0.5× 23 916
Markus Jahn Germany 12 418 0.7× 181 0.7× 170 0.9× 138 0.8× 242 1.5× 15 1.1k
Stacey Gauny United States 15 230 0.4× 110 0.4× 168 0.9× 163 0.9× 225 1.4× 29 679
Mayumi Nishimura Japan 19 369 0.6× 252 1.0× 247 1.3× 26 0.2× 373 2.3× 68 1.0k
Marek Pruszyński Poland 20 1.1k 1.7× 348 1.4× 320 1.7× 125 0.7× 250 1.5× 40 1.4k
Ronald E. Weiner United States 15 378 0.6× 161 0.6× 90 0.5× 54 0.3× 213 1.3× 35 824
Keisuke Sugimoto Japan 12 116 0.2× 234 0.9× 286 1.5× 127 0.7× 232 1.4× 65 931
Maite Jauregui‐Osoro United Kingdom 15 313 0.5× 97 0.4× 63 0.3× 118 0.7× 148 0.9× 19 696

Countries citing papers authored by Lara L. Chappell

Since Specialization
Citations

This map shows the geographic impact of Lara L. Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara L. Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara L. Chappell more than expected).

Fields of papers citing papers by Lara L. Chappell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara L. Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara L. Chappell. The network helps show where Lara L. Chappell may publish in the future.

Co-authorship network of co-authors of Lara L. Chappell

This figure shows the co-authorship network connecting the top 25 collaborators of Lara L. Chappell. A scholar is included among the top collaborators of Lara L. Chappell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara L. Chappell. Lara L. Chappell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chappell, Lara L., et al.. (2009). Arsenic in Seafood: Speciation Issues for Human Health Risk Assessment. Human and Ecological Risk Assessment An International Journal. 15(1). 185–200. 52 indexed citations
2.
Blackburn, Karen, et al.. (2005). Application of the threshold of toxicological concern approach to ingredients in personal and household care products. Regulatory Toxicology and Pharmacology. 43(3). 249–259. 56 indexed citations
3.
Milenic, Diane E., Kayhan Garmestani, Ekaterina Dadachova, et al.. (2004). Radioimmunotherapy of Human Colon Carcinoma Xenografts Using a 213 Bi-Labeled Domain-Deleted Humanized Monoclonal Antibody. Cancer Biotherapy and Radiopharmaceuticals. 19(2). 135–147. 46 indexed citations
4.
Chappell, Lara L., Dangshe Ma, Diane E. Milenic, et al.. (2003). Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid for radiolabeling proteins. Nuclear Medicine and Biology. 30(6). 581–595. 51 indexed citations
5.
Milenic, Diane E., Kayhan Garmestani, Lara L. Chappell, et al.. (2002). In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications. Nuclear Medicine and Biology. 29(4). 431–442. 96 indexed citations
6.
Kennel, Stephen J., Lara L. Chappell, Martin W. Brechbiel, et al.. (2000). Evaluation of 225 Ac for Vascular Targeted Radioimmunotherapy of Lung Tumors. Cancer Biotherapy and Radiopharmaceuticals. 15(3). 235–244. 69 indexed citations
7.
Adams, Gregory P., Calvin Shaller, Lara L. Chappell, et al.. (2000). Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules. Nuclear Medicine and Biology. 27(4). 339–346. 73 indexed citations
8.
Chappell, Lara L., Ekaterina Dadachova, Diane E. Milenic, et al.. (2000). Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb. Nuclear Medicine and Biology. 27(1). 93–100. 123 indexed citations
9.
Kennel, Stephen J., Saed Mirzadeh, Gregory B. Hurst, et al.. (2000). Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors. Nuclear Medicine and Biology. 27(8). 815–825. 22 indexed citations
10.
Chappell, Lara L., et al.. (2000). Eu(III) Macrocyclic Complexes Promote Cleavage of and Bind to Models for the 5‘-Cap of mRNA. Effect of Pendent Group and a Second Metal Ion. Inorganic Chemistry. 39(10). 2130–2134. 74 indexed citations
11.
Huang, Ling, Lara L. Chappell, Olga Iranzo, Brenda F. Baker, & Janet R. Morrow. (2000). Oligonucleotide conjugates of Eu(III) tetraazamacrocycles with pendent alcohol and amide groups promote sequence-specific RNA cleavage. JBIC Journal of Biological Inorganic Chemistry. 5(1). 85–92. 44 indexed citations
12.
Chappell, Lara L., Kim A. Deal, Ekaterina Dadachova, & Martin W. Brechbiel. (2000). Synthesis, Conjugation, and Radiolabeling of a Novel Bifunctional Chelating Agent for 225Ac Radioimmunotherapy Applications. Bioconjugate Chemistry. 11(4). 510–519. 65 indexed citations
13.
Dadachova, Ekaterina, Lara L. Chappell, & Martin W. Brechbiel. (1999). Spectrophotometric method for determination of bifunctional macrocyclic ligands in macrocyclic ligand–protein conjugates. Nuclear Medicine and Biology. 26(8). 977–982. 64 indexed citations
14.
Chappell, Lara L., Buck E. Rogers, M.B. Khazaeli, et al.. (1999). Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N′,N″,N‴-tris(acetic acid)cyclododecane (PA-DOTA). Bioorganic & Medicinal Chemistry. 7(11). 2313–2320. 34 indexed citations
15.
Buchsbaum, Donald J., Buck E. Rogers, M B Khazaeli, et al.. (1999). Targeting strategies for cancer radiotherapy.. PubMed. 5(10 Suppl). 3048s–3055s. 31 indexed citations
16.
Chappell, Lara L., et al.. (1998). Determination of enantiomeric purity of commercial 14C- and 3H-labeled L-α-amino acids. Journal of Labelled Compounds and Radiopharmaceuticals. 41(6). 477–489. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026